Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

Update Il y a 4 ans
Reference: NCT01161147

Woman and Man

  • | Country :
  • Canada
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Boehringer Ingelheim Pharmaceuticals Inc., USA) under fed conditions.


Inclusion criteria

  • Healthy

Links